Localization of phosphorylated alphaB-crystallin to heart mitochondria during ischemia-reperfusion

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H337-44. doi: 10.1152/ajpheart.00881.2007. Epub 2007 Nov 9.

Abstract

The cytosolic small heat shock protein alphaB-crystallin (alphaBC) is a molecular chaperone expressed in large quantities in the heart, where it protects from stresses such as ischemia-reperfusion (I/R). Upon I/R, p38 MAP kinase activation leads to phosphorylation of alphaBC on Ser(59) (P-alphaBC-S59), which increases its protective ability. alphaBC confers protection, in part, by interacting with and affecting the functions of key components in stressed cells. We investigated the hypothesis that protection from I/R damage in the heart by P-alphaBC-S59 can be mediated by localization to mitochondria. We found that P-alphaBC-S59 localized to mitochondria isolated from untreated mouse hearts and that this localization increased more than threefold when the hearts were subjected to ex vivo I/R. Mitochondrial P-alphaBC-S59 decreased when hearts were treated with the p38 inhibitor SB-202190. Moreover, SB-202190-treated hearts exhibited more tissue damage and less functional recovery upon reperfusion than controls. I/R activates mitochondrial permeability transition (MPT) pore opening, which increases cell damage. We found that mitochondria incubated with a recombinant mutant form of alphaBC that mimics P-alphaBC-S59 exhibited decreased calcium-induced MPT pore opening. These results indicate that mitochondria may be among the key components in stressed cells with which P-alphaBC-S59 interacts and that this localization may protect the myocardium, in part, by modulating MPT pore opening and, thus, reducing I/R injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cytosol / metabolism
  • Female
  • Imidazoles / pharmacology
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C3H
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / enzymology
  • Mitochondria, Heart / metabolism*
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Mutation
  • Myocardial Reperfusion Injury / enzymology
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / prevention & control*
  • Myocardium / enzymology
  • Myocardium / metabolism*
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Pyridines / pharmacology
  • Recombinant Proteins / metabolism
  • Subcellular Fractions / metabolism
  • Time Factors
  • alpha-Crystallin B Chain / genetics
  • alpha-Crystallin B Chain / metabolism*
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Imidazoles
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Protein Kinase Inhibitors
  • Pyridines
  • Recombinant Proteins
  • alpha-Crystallin B Chain
  • p38 Mitogen-Activated Protein Kinases
  • 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole
  • Calcium